Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diabetic neuropathy, Electromyogram, Electrophoresis, Fibroma
Clinical narrative: Infection SARS-COV-2 in May2022; Infection SARS-COV-2 in May2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), on 14Jun2021 as dose 1, single (Lot number: EW0186, Expiration Date: 31Aug2021) intramuscular, in left deltoid and on 05Jul2021 as dose 2, single (Lot number: EW0180) at the age of 41 years for covid-19 immunisation. The patient's relevant medical history included: "Juvenil Diabetes Mellitus" (unspecified if ongoing); "quadriparesis" (unspecified if ongoing), notes: Developing with quadriparesis mostly in pelvic members; "COVID", start date: May2020 (unspecified if ongoing), notes: COVID in May2020. Concomitant medication(s) included: AMITRIPTYLINE; PREGABALINE; MORPHINE.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Infection SARS-COV-2 in May2022". The patient underwent the following laboratory tests and procedures: Antibody test: (unspecified date) Negative, notes: Reumatology Antibodies Negative; Biopsy: (unspecified date) Unknown results, notes: periumbilical fat without data deposits of amiloids biopsy; Biopsy skin: (unspecified date) Unknown results; Body height: (unspecified date) 1.75; Body temperature: (unspecified date) 36.5; Diabetic neuropathy: (unspecified date) Unknown results; Electromyogram: (unspecified date) Unknown results, notes: Abnormal Electromyogram with electrophysiologicalevidence of: Chronic Axonal Polyneuropathy, distal affection, with incipient reinnervation; (unspecified date) Thoracic And Pelvic Members, notes: Electromyographic Report: Thoracic And Pelvic Members; Electrophoresis: (unspecified date) Normal, notes: Electrophoresis In Serum Normal; Fibroma: (unspecified date) Unknown results; Glycosylated haemoglobin: (Mar2021) 9.4%, notes: Glycosylated Hemoglobin in Mar2021 9.4%; Intrinsic factor antibody: (unspecified date) Negative, notes: Antibodies Against Parietal Cells And Intrinsic Factor Negatives -Vchemg With Axonal Neuropathy; Light chain analysis normal: (unspecified date) Normal; Magnetic resonance imaging: (unspecified date) Unknown results; Neoplasm malignant: (unspecified date) Negative; Nerve conduction studies normal: (unspecified date) Normal; Parietal cell antibody: (unspecified date) Negative; Polyneuropathy: (unspecified date) Unknown results; SARS-CoV-2 test: (May2020) Positive, notes: COVID in May 2020; (May2022) Positive; Vitamin B12: (unspecified date) Low; Weight: (unspecified date) 95.  Additional Information: Chief Complaint: covid vaccine complications. visit date: 10sep2022 16:40. emergency department care providers. procedures performed during visit: severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease (covid-19)) vaccine, mrna-inp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use. diagnosis: polyneuropathy unspecified. risk factors chronic ingestion of drugs, arterial hypertension, chronic illness, tuberculosis, alergens, diabetic, others. patient who presents difficulty walking since today early morning and suffers a fall of secondary sustrebctation difficulty walking, suffers a minor bump on parietal region of skull, rest interrogated and denied, at the moment he cant walk still even with support, nomocephalic skull, cardiopulmonar thorax without compromise, abdomen sdp, extremities with decreased strength in lower extremities 3/5 daniels scale.